GSK application for Shingrix for shingles prevention in at-risk adults aged 18 and over accepted for review in China
We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok